Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

RCT (n=179) found that influenza positive illness was detected in 29% of patients given an oral influenza vaccine vs 35% given intramuscular inactivated influenza vaccine and 48% given placebo after challenge. The oral vaccine was reported to be well tolerated.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news